2020
DOI: 10.1016/j.bioorg.2020.104457
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and biological assessment of acridine derivatives containing 1,3,4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 46 publications
0
6
0
Order By: Relevance
“…The anticholinesterases are also used to manage other forms of neurological disorders, such as ataxia, PD, dementia with Lewy bodies, senile dementia, vascular dementia, Down's syndrome, Korsakoff disease, and myasthenia gravis (Farmakidis et al, 2018; Kulshreshtha & Piplani, 2016; Mukherjee et al, 2007). Nowadays, there are worldwide research efforts for the design and development of novel cholinesterase inhibitors with more efficacy and fewer side effects (Lotfi et al, 2020; Mariki et al, 2021; Sharma, 2019). The identification of new potent anticholinesterase compounds through the study of natural resources has also attracted a lot of attention (Dey et al, 2017; Dos Santos et al, 2018; Houghton et al, 2006; Mukherjee et al, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…The anticholinesterases are also used to manage other forms of neurological disorders, such as ataxia, PD, dementia with Lewy bodies, senile dementia, vascular dementia, Down's syndrome, Korsakoff disease, and myasthenia gravis (Farmakidis et al, 2018; Kulshreshtha & Piplani, 2016; Mukherjee et al, 2007). Nowadays, there are worldwide research efforts for the design and development of novel cholinesterase inhibitors with more efficacy and fewer side effects (Lotfi et al, 2020; Mariki et al, 2021; Sharma, 2019). The identification of new potent anticholinesterase compounds through the study of natural resources has also attracted a lot of attention (Dey et al, 2017; Dos Santos et al, 2018; Houghton et al, 2006; Mukherjee et al, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…Anticholinesterase (AChE) activity evaluation of the derivatives showed that all the derivatives are capable of inhibiting both enzymes and are highly selective towards AChE. Among them, the ability of 163 and 164 with respective IC 50 values of 0.002 and 0.006 µM to inhibit AChE was higher than tacrine (IC 50 = 0.016 µM) 235 ( Table 6 ).…”
Section: Synthetic Cholinesterase Inhibitorsmentioning
confidence: 99%
“…Since these heterocyclic rings are compounds with a broad spectrum of biological activity they are important pharmacophores in medicinal chemistry [28–35] . Additionally, 1,2,4‐triazole and 1,3,4‐thiadiazole derivates are active compounds as cholinesterase inhibitors for the treatment of AD [36–40] …”
Section: Introductionmentioning
confidence: 99%
“…[28][29][30][31][32][33][34][35] Additionally, 1,2,4-triazole and 1,3,4-thiadiazole derivates are active compounds as cholinesterase inhibitors for the treatment of AD. [36][37][38][39][40] Molecular hybridization is a concept based on combining different bioactive pharmacophores to design and obtain new compounds with less side effects and higher biological activity. [41] In this study, new hybrid molecules benzoxazoloneÀ thiosemicarbazide, benzoxazoloneÀ 1,2,4triazole and benzoxazoloneÀ 1,3,4-thiadiazole were designed and synthesized by combining the active pharmacophores thiosemicarbazide, 1,2,4-triazole and 1,3,4-thiadiazole with benzoxazolone (Figure 2).…”
Section: Introductionmentioning
confidence: 99%